Preparation and hypoglycemic effects of chromium- and zinc-rich Acetobacter aceti

Figure 1 Detection of hypoglycemic components of chromium- and zinc-rich Acetobacter aceti. A: Concentration of chromium and zinc; B: Concentration of dihydronicotinamide-adenine dinucleotide; C: Concentration of glucuronic acid dehydrogenase.

Figure 2 Evaluation of hypoglycemic effects of chromium- and zinc-rich Acetobacter aceti on mice with diabetes.

Figure 3 Repair effect of chromium- and zinc-rich Acetobacter aceti on tissues and cells of pancreatic islets.

Figure 4 Effects of chromium- and zinc-rich Acetobacter aceti on weight recovery of diabetic mice.

Figure 5 Effects of chromium- and zinc-rich Acetobacter aceti on promoting growth of pancreatic islet cells MIN6. A: 5 mmol/L glucose; B: 25 mmol/L glucose. ^aP < 0.05; ^bP < 0.01.

Figure 6 Effects of chromium- and zinc-rich Acetobacter aceti on facilitating growth and insulin secretion of islet MIN6 cells. A: 5 mmol/L glucose; B: 25 mmol/L glucose. ^bP < 0.01; ^cP < 0.001.

Figure 7 Capacity of chromium- and zinc-rich Acetobacter aceti for processing glucose. ^bP < 0.01.

Figure 8 Safety evaluation of chromium- and zinc-rich Acetobacter aceti.